BlackRock’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.3M Sell
4,733,929
-422,474
-8% -$1.55M ﹤0.01% 3070
2025
Q1
$22.3M Sell
5,156,403
-119,618
-2% -$517K ﹤0.01% 2837
2024
Q4
$16.9M Sell
5,276,021
-53,391
-1% -$171K ﹤0.01% 3107
2024
Q3
$15.2M Buy
5,329,412
+242,266
+5% +$693K ﹤0.01% 3155
2024
Q2
$14.2M Buy
5,087,146
+112,845
+2% +$316K ﹤0.01% 3124
2024
Q1
$14.1M Sell
4,974,301
-223,886
-4% -$636K ﹤0.01% 3120
2023
Q4
$21.3M Buy
5,198,187
+253,037
+5% +$1.03M ﹤0.01% 2934
2023
Q3
$15.7M Buy
4,945,150
+99,857
+2% +$318K ﹤0.01% 3027
2023
Q2
$16.1M Buy
4,845,293
+356,680
+8% +$1.18M ﹤0.01% 3104
2023
Q1
$9.56M Sell
4,488,613
-6,614,577
-60% -$14.1M ﹤0.01% 3270
2022
Q4
$29.9M Buy
11,103,190
+566,429
+5% +$1.52M ﹤0.01% 2764
2022
Q3
$34.1M Buy
10,536,761
+861,588
+9% +$2.79M ﹤0.01% 2692
2022
Q2
$47.2M Buy
9,675,173
+22,985
+0.2% +$112K ﹤0.01% 2505
2022
Q1
$73.6M Buy
9,652,188
+1,412,356
+17% +$10.8M ﹤0.01% 2307
2021
Q4
$76.1M Buy
8,239,832
+165,724
+2% +$1.53M ﹤0.01% 2361
2021
Q3
$115M Buy
8,074,108
+1,052,935
+15% +$15M ﹤0.01% 2101
2021
Q2
$117M Buy
7,021,173
+4,730,593
+207% +$78.6M ﹤0.01% 2145
2021
Q1
$41.7M Buy
2,290,580
+1,026,183
+81% +$18.7M ﹤0.01% 2700
2020
Q4
$9.52M Buy
1,264,397
+206,412
+20% +$1.55M ﹤0.01% 3318
2020
Q3
$4.06M Sell
1,057,985
-4,398
-0.4% -$16.9K ﹤0.01% 3558
2020
Q2
$4.08M Buy
1,062,383
+411,298
+63% +$1.58M ﹤0.01% 3529
2020
Q1
$2.1M Buy
651,085
+23,052
+4% +$74.5K ﹤0.01% 3573
2019
Q4
$3.02M Buy
628,033
+35,645
+6% +$171K ﹤0.01% 3599
2019
Q3
$3.89M Buy
592,388
+37,550
+7% +$247K ﹤0.01% 3508
2019
Q2
$4.22M Buy
554,838
+486,870
+716% +$3.7M ﹤0.01% 3528
2019
Q1
$510K Buy
+67,968
New +$510K ﹤0.01% 4048